OTC · PLSH
Healthcare · Drug Manufacturers - Specialty & Generic
$0.09
Up+$0.00 (+0.00%)
Updated Oct 10, 2026, 1:26 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · PLSH
1M range · 13 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
PLSH closed at $0.09 after 13 trading sessions, down 15.00% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $0.085 | $0.085 | $0.085 | $0.085 | 1K |
| Oct 5, 2026 | $0.0819 | $0.0819 | $0.066 | $0.066 | 6.57K |
| Oct 2, 2026 | $0.0819 | $0.085 | $0.064 | $0.085 | 3.03K |
| Oct 1, 2026 | $0.0819 | $0.085 | $0.06 | $0.06 | 12.51K |
| Sep 30, 2026 | $0.085 | $0.085 | $0.085 | $0.085 | 240 |
| Sep 29, 2026 | $0.0819 | $0.0819 | $0.0819 | $0.0819 | 250 |
| Sep 25, 2026 | $0.08 | $0.08 | $0.08 | $0.08 | 1.07K |
| Sep 24, 2026 | $0.0819 | $0.0819 | $0.0782 | $0.0782 | 1.1K |
| Sep 21, 2026 | $0.085 | $0.085 | $0.085 | $0.085 | 500 |
| Sep 17, 2026 | $0.07 | $0.0725 | $0.07 | $0.0725 | 17.7K |
| Sep 16, 2026 | $0.076 | $0.085 | $0.07 | $0.085 | 92.95K |
| Sep 15, 2026 | $0.0923 | $0.0923 | $0.0923 | $0.0923 | 100 |
| Sep 11, 2026 | $0.10 | $0.10 | $0.10 | $0.10 | 10.01K |
The latest Smart Investors Daily articles mentioning PLSH.
Company
Market Activity
Research & News
PLSH research
Company profile and research snapshot.
PANACEA LIFE SCIENCE HLD
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Nov 18, 2025
Panacea Life Sciences Holdings and Benivita Inc. launched a new direct-to-consumer virtual benefits platform offering affordable telemedicine and lifestyle wellness services, targeting underserved markets with plans starting at $59.95 per month.
GlobeNewswire Inc. · May 16, 2024
GOLDEN, Colo., May 16, 2024 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) (“Panacea Life Sciences,” “PLSH” or the “Company”), a Colorado-based manufacturing, research and product development company in the natural health and wellness industry, announces the execution of a Supply, Licensing and Development Agreement (Agreement) by its subsidiary, Panacea Life Sciences, Inc. with Sky Wellness, LLC for the marketing and sale of Sky Wellness’ current CBD product inventory and the licensing and development of new products under the trademarked family of Sky Wellness brands.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PLSH.
No results
No recent SID articles mention PLSH.
